This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

6 Jun 2012

Dr Reddy's And Merck Announce Biosimilars Collaboration

Dr Reddy's Laboratories and Merck Serono will work together to develop cheaper versions of cancer biologics.

Dr Reddy's Laboratories has announced a new collaboration with Merck Serono which will see the two companies work together to develop biosimilars in the field of oncology.


In particular, the companies hope to develop low-cost generic versions of monoclonal antibodies (MABs) for use when their patents have expired.


Dr Reddy's - which has already launched four biosimilar molecules - will take the lead on early product development and phase-I clinical testing.


After this, Merck Serono will lead phase-III development and take over the manufacture of the compounds.


Research and development costs will be shared bet

Related News